Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to evaluate the efficacy and safety of three doses of GSK573719 (125, 250, and 500 mcg once daily) compared with placebo in subjects with COPD in order to inform the selection of an optimal effective and safe dose for future clinical development programs.
Critère d'inclusion
- Chronic Obstructive Pulmonary Disease